Significantly higher GDF15 levels were noted in the patients with PAD compared to the controls (3448.7 (1713.5–5427.9) versus 535.0 (415.3–716.5) pg/mL, adjusted P < 0.001). This evidence concerns the gene GDF15 and peripheral arterial disease.